86-21-64556180 ib

NF- IB

CAT # Khoom npe Kev piav qhia
PEB 3237 CDDU-Me
PEB 3619 PEB 3619
PEB 3236 PEB 3236
PEB 3235 PEB 3235
TIAB SA 0995 Bardoxolone methyl hmoov Cov hluavtaws oleanane triterpenoid CDDO (Khoom No. 81035) yog Nrf2 activator uas inhibits proliferation thiab induces sib txawv thiab apoptosis nyob rau hauv ntau yam qog nqaij hlav cancer.
PIB 1017 Bardoxolone Bardoxolone yog ib qho tshiab nuclear regulator yam (Nrf-2) activator.
TIAB SA 1661 TSI-901 IT-901 yog C-Rel Inhibitor Uas Kho Mob Cov Khoom Siv Tshuaj Tiv Thaiv Kab Mob hauv Hematologic Malignancies los ntawm Thaiv NF-κB-Controlled Oxidative Stress Responses.
ua

Tiv tauj peb

Kev nug

Xov xwm tshiab

  • Sab saum toj 7 trends hauv Pharmaceutical Research Hauv 2018

    Sab saum toj 7 Trends Hauv Pharmaceutical Research Kuv ...

    Nyob rau hauv ib txwm muaj-nce siab los sib tw nyob rau hauv ib tug nyuaj kev lag luam thiab thev naus laus zis ib puag ncig, kws tshuaj thiab biotech tuam txhab uas muag yuav tsum txuas ntxiv innovate nyob rau hauv lawv cov R & D cov kev pab cuam nyob rau hauv ...

  • ARS-1620: Kev cog lus tshiab inhibitor rau KRAS-mutant qog noj ntshav

    ARS-1620: Kev cog lus tshiab inhibitor rau K ...

    Raws li kev tshawb fawb luam tawm hauv Cell, cov kws tshawb fawb tau tsim ib qho inhibitor tshwj xeeb rau KRASG12C hu ua ARS-1602 uas ua rau cov qog nqaij hlav hauv cov nas. "Qhov kev tshawb fawb no muab pov thawj hauv vivo tias mutant KRAS tuaj yeem yog ...

  • AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau cov tshuaj oncology

    AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau ...

    AstraZeneca tau txais kev txhawb nqa ob npaug rau nws cov ntaub ntawv kho mob oncology rau hnub Tuesday, tom qab Asmeskas thiab European cov neeg tswj hwm tau txais kev tswj hwm kev xa tawm rau nws cov tshuaj, thawj kauj ruam ntawm kev pom zoo rau cov tshuaj no. ...

WhatsApp pawg online sib tham!